Photodynamic therapy with visudyne (verteporfin) (QLT Inc.) for central serous retinopathy (CSR)

Record ID 32010000933
English
Authors' objectives:

Central serous retinopathy (CSR) occurs when fluid leaks from capillaries in the choroidal layer, which lies between the retina and the outer surface of the eye, causing detachment of the retina and distortion of vision. Although the cause of CSR is unknown, one survey indicated that each year, it occurs in 9.9 out of every 100,000 men and in 1.7 out of every 100,000 women. Since retinal detachment can also occur due to inflammation, cancer, and growth of abnormal new blood vessels in the retina, these disorders must be ruled out to establish a diagnosis of CSR. Laser photocoagulation is a widely accepted therapy for CSR; however, most patients are encouraged to delay use of this therapy since patients with CSR usually get better without any treatment.

Details
Project Status: Completed
URL for project: http://www.hayesinc.com
Year Published: 2009
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Photochemotherapy
  • Photosensitizing Agents
  • Porphyrins
Contact
Organisation Name: HAYES, Inc.
Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name: saleinfo@hayesinc.com
Contact Email: saleinfo@hayesinc.com
Copyright: 2010 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.